The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Kymarabine     4-amino-1-[3,4-dihydroxy-5...

Synonyms: AGN-PC-00K14Z, Ara AC, SureCN1249475, SureCN6672394, ACMC-209hqi, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Azacitidine


Psychiatry related information on Azacitidine


High impact information on Azacitidine


Chemical compound and disease context of Azacitidine


Biological context of Azacitidine


Anatomical context of Azacitidine


Associations of Azacitidine with other chemical compounds


Gene context of Azacitidine


Analytical, diagnostic and therapeutic context of Azacitidine


  1. 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia. Ley, T.J., DeSimone, J., Anagnou, N.P., Keller, G.H., Humphries, R.K., Turner, P.H., Young, N.S., Keller, P., Nienhuis, A.W. N. Engl. J. Med. (1982) [Pubmed]
  2. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. Letvin, N.L., Linch, D.C., Beardsley, G.P., McIntyre, K.W., Nathan, D.G. N. Engl. J. Med. (1984) [Pubmed]
  3. Brief report: treatment with azacitidine of patients with end-stage beta-thalassemia. Lowrey, C.H., Nienhuis, A.W. N. Engl. J. Med. (1993) [Pubmed]
  4. Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells. Niwa, O., Yokota, Y., Ishida, H., Sugahara, T. Cell (1983) [Pubmed]
  5. Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Boyd, A.W., Schrader, J.W. Nature (1982) [Pubmed]
  6. Differential chromosome sensitivity to 5-azacytidine in Alzheimer's disease. Payão, S.L., Smith, M.D., Bertolucci, P.H. Gerontology. (1998) [Pubmed]
  7. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Lassar, A.B., Davis, R.L., Wright, W.E., Kadesch, T., Murre, C., Voronova, A., Baltimore, D., Weintraub, H. Cell (1991) [Pubmed]
  8. Reactivation of thyroglobulin gene expression in transformed thyroid cells by 5-azacytidine. Avvedimento, E.V., Obici, S., Sanchez, M., Gallo, A., Musti, A., Gottesman, M.E. Cell (1989) [Pubmed]
  9. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Davis, R.L., Weintraub, H., Lassar, A.B. Cell (1987) [Pubmed]
  10. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Lassar, A.B., Paterson, B.M., Weintraub, H. Cell (1986) [Pubmed]
  11. Altering gene expression with 5-azacytidine. Jones, P.A. Cell (1985) [Pubmed]
  12. Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice. Presant, C.A., Coulter, D., Valeriote, F., Vietti, T.J. J. Natl. Cancer Inst. (1981) [Pubmed]
  13. Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma. Carlow, D.A., Kerbel, R.S., Feltis, J.T., Elliott, B.E. J. Natl. Cancer Inst. (1985) [Pubmed]
  14. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. Quddus, J., Johnson, K.J., Gavalchin, J., Amento, E.P., Chrisp, C.E., Yung, R.L., Richardson, B.C. J. Clin. Invest. (1993) [Pubmed]
  15. Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Haspel, M.V., Lampert, P.W., Oldstone, M.B. Proc. Natl. Acad. Sci. U.S.A. (1978) [Pubmed]
  16. Dynamic analysis of proviral induction and De Novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression. Lorincz, M.C., Schübeler, D., Goeke, S.C., Walters, M., Groudine, M., Martin, D.I. Mol. Cell. Biol. (2000) [Pubmed]
  17. Cellular differentiation, cytidine analogs and DNA methylation. Jones, P.A., Taylor, S.M. Cell (1980) [Pubmed]
  18. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Taylor, S.M., Jones, P.A. Cell (1979) [Pubmed]
  19. 5-Azacytidine permits gene activation in a previously noninducible cell type. Chiu, C.P., Blau, H.M. Cell (1985) [Pubmed]
  20. 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination. Konieczny, S.F., Emerson, C.P. Cell (1984) [Pubmed]
  21. DNA methylation controls the inducibility of the mouse metallothionein-I gene lymphoid cells. Compere, S.J., Palmiter, R.D. Cell (1981) [Pubmed]
  22. Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation. Groudine, M., Eisenman, R., Weintraub, H. Nature (1981) [Pubmed]
  23. Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine. Frost, P., Liteplo, R.G., Donaghue, T.P., Kerbel, R.S. J. Exp. Med. (1984) [Pubmed]
  24. Frequency of reactivation and variability in expression of X-linked enzyme loci. Mohandas, T., Sparkes, R.S., Bishop, D.F., Desnick, R.J., Shapiro, L.J. Am. J. Hum. Genet. (1984) [Pubmed]
  25. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Li, H., Myeroff, L., Smiraglia, D., Romero, M.F., Pretlow, T.P., Kasturi, L., Lutterbaugh, J., Rerko, R.M., Casey, G., Issa, J.P., Willis, J., Willson, J.K., Plass, C., Markowitz, S.D. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  26. Role of late replication timing in the silencing of X-linked genes. Hansen, R.S., Canfield, T.K., Fjeld, A.D., Gartler, S.M. Hum. Mol. Genet. (1996) [Pubmed]
  27. Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. Visvader, J., Adams, J.M. Blood (1993) [Pubmed]
  28. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Chahinian, A.P., Pajak, T.F., Holland, J.F., Norton, L., Ambinder, R.M., Mandel, E.M. Ann. Intern. Med. (1982) [Pubmed]
  29. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Santini, V., Kantarjian, H.M., Issa, J.P. Ann. Intern. Med. (2001) [Pubmed]
  30. Autologous transplantation of bone marrow cells improves damaged heart function. Tomita, S., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.J., Sakai, T., Jia, Z.Q. Circulation (1999) [Pubmed]
  31. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. Wheeler, J.M., Beck, N.E., Kim, H.C., Tomlinson, I.P., Mortensen, N.J., Bodmer, W.F. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
WikiGenes - Universities